Article
New Guidelines for Managing Immunotherapy-Related Adverse Events
ONS’s Pamela Ginex, EdD, MPH, RN, OCN®, discusses the new immunotherapy toxicity guidelines released by the National Comprehensive Cancer Network and the American Society of Clinical Oncology. We talk about ONS’s role in helping to develop the information, the importance of educating oncology nurses about immunotherapy-related side effects, as well as the new resources available for providers and patients.
Related Topics
You May Also Like
Article
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
Podcast
Hiring Managers Beware: Reverse Rejection Explained!
Article
The Talent Inflection Point in Pharma and Biotech: A Challenge to Companies — and a Call to Candidates
Article
Clinical Educator Oncology Program Improves Adherence by 29%
Article